Ośrodek Transferu Technologii Farmaceutycznych Uniwersytetu Medycznego w Białymstokusp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-06-30
Share capital
100,000.00 PLN
Registered address
Akademicka 3, 15-267 Białystok, Poland
Electronic delivery address
AE:PL-31563-83057-SIJRV-12

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 104 days early.

  • 202508/05/2026
  • 202404/04/2025
  • 202325/03/2024
  • 202210/03/2023
  • 202115/06/2022
  • 202015/04/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Other printing568 / 678
Top 84%
Top 79%
Sector · Manufacturing20,321 / 24,467
Top 83%
City · Białystok2,214 / 3,196
Top 69%
Voivodeship · Podlaskie4,095 / 5,647
Top 73%
Country · Poland210,659 / 297,932
Top 71%

Results vs industry

Revenue
This companyUSD 66.44kMedianUSD 391.25kAverageUSD 3.82m
Net profit
This companyUSD 685.71MedianUSD 11.59kAverageUSD 250.16k
Operating costs
This companyUSD 65.25kMedianUSD 352.97kAverageUSD 3.48m
Assets
This companyUSD 62.62kMedianUSD 243.10kAverageUSD 3.26m

Authorized Representatives

Elżbieta Skrzydlewskaage 66 – President of the Management Board
Katarzyna Zielińskaage 62 – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Uniwersytet Medyczny w Białymstoku
100$27,012.43100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2014-09-06.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$574

FAQ

Last updated: 2026-10-07